Billerica, Mass., USA - August 14, 2017, Billerica, Mass., USA - Insulet Corporation, a medical device company, announced the appointments of Michael R. Minogue and James C. Mullen to the company’s board of directors.
Article continues below
]
Michael R. Minogue has served on Insulet Board of Directors since August 2017.
He currently serves as Chief Executive Officer, President and Chairman of Abiomed.
He joined Abiomed from GE Healthcare, where he holds three patents and spent 11 years developing expertise in sales, marketing, product development, information technologies and software/service operations.
Mr. Minogue currently serves on the Board of Directors of AdvaMed and as Chairman of Medical Device Innovation Consortium, a public-private partnership with the industry, government and nonprofits.
Mr. Minogue is also Chairman of the Governor’s Advisory Council on Veterans’ Services for the Commonwealth of Massachusetts.
He is also on the Board of Managers for Bioventus LLC and recently stepped down from his position as Chairman after concluding ten years of service on the Board of Directors for MassMEDIC.
Mr. Minogue is the Co-Founder and Chairman of the Mentoring Veterans Program (MVPvets), a nonprofit organization that helps military veterans network with industry mentors to discover career opportunities in the life sciences industries.
He served as an Infantry officer in the U.S. Army, which included multiple distinctions, including Airborne Ranger, Desert Storm Veteran and he was awarded the Bronze Star.
Mr. Minogue received a Bachelor of Science, Engineering Management from the United States Military Academy at West Point and an MBA from the University of Chicago.
James C. Mullen has served on Insulet Board of Directors since August 2017.
Since 2011, Mr. Mullen has been Chief Executive Officer of Patheon which recently announced an agreement to be acquired by Thermo Fisher Scientific Inc.
Prior to joining Patheon, from 2003 to 2010, Mr. Mullen served as Chief Executive Officer and President at Biogen, one of the world's largest biotechnology companies.
Mr. Mullen held various operating positions at Biogen prior to becoming Chief Executive Officer, including Vice President, Operations, as well as several key manufacturing and engineering positions and spent over nine years at SmithKline Beecham.
He previously served on the Board of Directors of PerkinElmer and also as Chairman of the Biotechnology Innovation Organization.
Mr. Mullen holds a Bachelor of Science in Chemical Engineering from Rensselaer Polytechnic Institute and a Master of Business Administration from Villanova University. ■